Stock DNTH DIANTHUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Dianthus Therapeutics, Inc.

Equities

DNTH

US2528281080

Real-time Estimate Cboe BZX
Other stock markets
 18:42:13 21/06/2024 BST 		5-day change 1st Jan Change
24.98 USD +0.40% Intraday chart for Dianthus Therapeutics, Inc. -7.72% +139.23%
06-12 Dianthus Therapeutics Secures US FDA Approval to Launch Phase 2 Study of DNTH103 in Multifocal Motor Neuropathy MT
06-12 Dianthus Therapeutics Gets FDA Clearance for DNTH103 Phase 2 Trial DJ

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Dianthus Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Dianthus Therapeutics, Inc. Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DNTH Stock
  4. News Dianthus Therapeutics, Inc.
  5. Highlights